Clinical and oncological outcomes of transanal total mesorectal excision considering the embryology along the fascia in rectal cancer patients: a propensity score-matched analysis
Authors:
Preprint
- 2 November 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose Transanal total mesorectal excision (TaTME) remains a challenging technique for rectal dissection. This study aims to evaluate the clinical and oncological outcomes of TaTME, compared to those of the laparoscopic total mesorectal excision (LaTME) in rectal cancer. Methods Using propensity score-matched analyses, we analyzed retrospective data from 134 consecutive patients with rectal cancer who underwent TaTME or LaTME from January 2011 to June 2020 in our hospital. Clinical and oncological outcomes were evaluated. The primary endpoint was the 2-year local recurrence rate. Results Before data analysis, significant group-dependent differences were observed only in the tumor height (p < 0.01). After analysis, preoperative patients’ demographics were similar between the TaTME and LaTME-defined groups. The operative time was significantly shorter in the TaTME group (p = 0.02), and the rates of hand-sewn anastomosis and protective loop ileostomy were significantly higher(p < 0.01). TaTME showed a 29% overall morbidity rate and LaTME 44%. Furthermore, the rate of Clavien–Dindo grade III tended to be lower in the TaTME group (p = 0.07). There were no statistically significant differences in terms of pathological findings, and the 2-year local recurrence rate was similar between the two groups (both 5.9%) Conclusions TaTME based on embryology along the fascia is feasible and seems a safe alternative to LaTME in selected patients with rectal cancer when considering the conversion rate and the operative time.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trialThe Lancet Oncology, 2014
- A pilot study of natural orifice transanal endoscopic total mesorectal excision with laparoscopic assistance for rectal cancerSurgical Endoscopy, 2013
- Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: “down-to-up” total mesorectal excision (TME)—short-term outcomes in the first 20 casesSurgical Endoscopy, 2013
- TAMIS-assisted laparoscopic low anterior resection with total mesorectal excision in a cadaveric seriesSurgical Endoscopy, 2013
- No-Scar Transanal Total Mesorectal ExcisionJAMA Surgery, 2013
- Feasibility study of transanal total mesorectal excisionBritish Journal of Surgery, 2013
- NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistanceSurgical Endoscopy, 2010
- Transanal minimally invasive surgery: a giant leap forwardSurgical Endoscopy, 2010
- Anterior Resection for Rectal Cancer With Mesorectal ExcisionAnnals of Surgery, 2004
- Classification of Surgical ComplicationsAnnals of Surgery, 2004